BA
KTOVW

BlackRock Advisors’s Kitov Pharma Ltd. Warrants KTOVW Stock Holding History

BlackRock Advisors’s Portfolio KTOVW Stock Details KTOVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$14K Sell
10,533
-1,161
-10% -$1.76K ﹤0.01% 3522
2016
Q3 		$13K Hold
11,694
– – ﹤0.01% 3539
2016
Q2 		$9K Sell
11,694
-5,431
-32% -$8.02K ﹤0.01% 3600
2016
Q1 		$19K Hold
17,125
– – ﹤0.01% 3444
2015
Q4 		$9K Buy
+17,125
New +$10.6K ﹤0.01% 3648

Other funds holding KTOVW

ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock Advisors's KTOVW Position: Q4 2016 in Review

BlackRock Advisors reduced its Kitov Pharma Ltd. Warrants (KTOVW) stake by 9.9% in Q4 2016, selling an estimated $1.76K and leaving 10,533 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #3522.

BlackRock Advisors first reported a position in KTOVW in Q4 2015 and has held it in 5 quarters since. The position peaked at $19K in Q1 2016. 3 funds tracked by Wall St. Rank hold KTOVW as of Q4 2016.

  • BlackRock Advisors held 10,533 shares of Kitov Pharma Ltd. Warrants worth $14K as of Q4 2016.
  • BlackRock Advisors sold 1,161 Kitov Pharma Ltd. Warrants shares in Q4 2016, an estimated $1.76K.
  • Kitov Pharma Ltd. Warrants made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3522 holding.
  • BlackRock Advisors first reported a position in Kitov Pharma Ltd. Warrants in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Advisors's Kitov Pharma Ltd. Warrants position peaked at $19K in Q1 2016.
  • 3 funds tracked by Wall St. Rank held Kitov Pharma Ltd. Warrants as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.